ArticleNeoReviews2016

The Role of Biomarkers and Surrogate End Points in Drug Development for Neonatal Pulmonary Arterial Hypertension.

Haihao Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.